Plenary presentation: The evolving ER+ HER2- mBC treatment landscape
07:50 - 08:03
Back to programme
Developments to address endocrine therapy resistance
MAT-GB-2105739 v(1.0)
Date of Prep: January 2022
Sponsor
Speakers
